79 related articles for article (PubMed ID: 8123225)
1. Immunomodifiers applicable to the prevention and management of infectious diseases in children.
La Pine TR; Hill HR
Adv Pediatr Infect Dis; 1994; 9():37-58. PubMed ID: 8123225
[TBL] [Abstract][Full Text] [Related]
2. Cytokines in the pathogenesis and treatment of infectious diseases.
Lau AS
Adv Pediatr Infect Dis; 1994; 9():211-36. PubMed ID: 7510110
[No Abstract] [Full Text] [Related]
3. Cytokines in the treatment of hematological disorders: recent progress and perspectives.
Robak T
Arch Immunol Ther Exp (Warsz); 1996; 44(1):5-9. PubMed ID: 8874763
[TBL] [Abstract][Full Text] [Related]
4. [Interferons. Interferons alpha and gamma: indications in systemic diseases].
Blétry O; Papo T
Ann Med Interne (Paris); 1993; 144(8):557-62. PubMed ID: 8179244
[TBL] [Abstract][Full Text] [Related]
5. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
6. [Clinical applications of cytokines in pediatrics].
Gadner H
Klin Padiatr; 1994; 206(1):2-11. PubMed ID: 8152201
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma.
Hübel K; Dale DC; Liles WC
J Infect Dis; 2002 May; 185(10):1490-501. PubMed ID: 11992286
[TBL] [Abstract][Full Text] [Related]
8. Cytokines and cytokine therapies in HIV infection.
Valdez H; Lederman MM
AIDS Clin Rev; 1997-1998; ():187-228. PubMed ID: 9305449
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic immunomodulation.
Galbraith GM
Dermatol Clin; 1988 Oct; 6(4):561-8. PubMed ID: 2465856
[TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
[TBL] [Abstract][Full Text] [Related]
11. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutic potentials of cytokines and growth factors in severe infections].
van der Meer JW; Weening RS
Ned Tijdschr Geneeskd; 1992 Jun; 136(24):1143-7. PubMed ID: 1376858
[No Abstract] [Full Text] [Related]
13. Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.
Safdar A; Rodriguez GH; Lichtiger B; Dickey BF; Kontoyiannis DP; Freireich EJ; Shpall EJ; Raad II; Kantarjian HM; Champlin RE
Cancer; 2006 Jun; 106(12):2664-71. PubMed ID: 16691620
[TBL] [Abstract][Full Text] [Related]
14. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.
Zhang SY; Boisson-Dupuis S; Chapgier A; Yang K; Bustamante J; Puel A; Picard C; Abel L; Jouanguy E; Casanova JL
Immunol Rev; 2008 Dec; 226():29-40. PubMed ID: 19161414
[TBL] [Abstract][Full Text] [Related]
15. [Cytokines in children with immunodeficiencies].
Kowalczyk D
Folia Med Cracov; 1999; 40(1-2):5-97. PubMed ID: 10909468
[TBL] [Abstract][Full Text] [Related]
16. Cytokine therapy for hematological malignancies.
Ezaki K; Tsuzuki M
Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():182-94. PubMed ID: 9210900
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapies in infectious diseases.
Kak V; Sundareshan V; Modi J; Khardori NM
Med Clin North Am; 2012 May; 96(3):455-74, ix. PubMed ID: 22703851
[TBL] [Abstract][Full Text] [Related]
18. [Alpha interferons--new therapeutic modalities].
Bajcetić M; Zigon N; Samardzić R; Beleslin DB
Med Pregl; 1998; 51(3-4):135-9. PubMed ID: 9611956
[TBL] [Abstract][Full Text] [Related]
19. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
[TBL] [Abstract][Full Text] [Related]
20. [Current status of the clinical application of hematopoietic growth factors in oncology].
Karthaus M; Ganser A
Ther Umsch; 1996 Nov; 53(11):863-73. PubMed ID: 8984692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
